A possible new drug for Mast Cell Activation Syndrome (MCAS) and Complex Regional Pain Syndrome (CRPS)

A possible new drug for Mast Cell Activation Syndrome (MCAS) and Complex Regional Pain Syndrome (CRPS)

Remibrutinib: What People Should Know

The quick take

Remibrutinib is a pill that has currently been approved for people with hives. It works on the Mast Cells and stops them. Hence, it may help people with MCAS. It also suppresses microglia and decreases inflammation in the central nervous system and may help CRPS. It has not been approved for MCAS or CRPS.

It helps many people with chronic hives (the medical name is chronic spontaneous urticaria, or CSU) when regular allergy pills haven’t worked. It can calm the inflammation caused by active Mast cells. Side effects have mostly been mild, like stuffy nose or headaches.

What is it?

•               It’s a medicine that turns down an overactive part of the immune system called BTK.

•               When that switch is too “on,” you can get hives and swelling. Remibrutinib helps turn it back toward normal.

Who is it for right now?

•               Adults with chronic hives who still have symptoms even after taking antihistamines (the usual allergy pills) – think MCAS

How well does it work for hives?

Think of a classroom of 100 people with tough hives:

•               After 12 weeks on remibrutinib, about 30 out of 100 people had no hives at all.

•               Another 15–20 out of 100 still had some hives, but they were small and rare (well-controlled).

•               On a sugar pill, those numbers were much lower (roughly 7–10 out of 100 with no hives).

Speed: Many people start feeling better in the first week or two. Relief can keep building over the next few months.

Is it safe?

So far, the safety looks reassuring in hive studies:

•               Common, usually mild issues: stuffy/runny nose, sore throat, headache.

•               Serious problems were rare and about the same as with a sugar pill in studies.

•               Doctors still keep an eye on infections and bruising, since this type of medicine works on immune cells. If you’re on blood thinners or get frequent infections, that’s a talk to have with your doctor.

How do you take it?

•               It’s an oral pill, taken twice a day.

•               No routine blood tests were required in the hive studies, but your own doctor may still check in on you.

What about angioedema (swelling of lips/eyelids)?

•               Some people with hives also get deep swelling. Remibrutinib can help, but if swelling is your main problem, your doctor may also talk about other options (including shots) depending on your history.

Who shouldn’t take it or should be careful?

•               People with active serious infections-clear that first.

•               If you’re on strong enzyme-boosting meds (some seizure drugs, certain antibiotics, or herbal products like St. John’s wort), the pill might not work as well. Bring your full med list to your doctor.

•               If you’re pregnant or breastfeeding, ask about risks vs benefits-data are limited.

Plain answers to common questions

“How soon will I know if it’s helping?”

Many notice less itch and fewer bumps within 1–2 weeks. Give it up to 12 weeks for the full picture.

“Will the hives come back if I stop?”

They can. Hives often come in waves. Your doctor will help plan how long to stay on it and what to do if symptoms return.

“Is it better than biologic shots?”

Different tools, different pros/cons. Remibrutinib is oral and fast; some shots have very strong data too, especially for certain patterns (like lots of swelling). Your doctor can help sequence options.

Bottom line

•               If you’ve got stubborn hives that laugh at antihistamines, remibrutinib is a serious, convenient option with quick relief for many and a side-effect profile that’s mostly mild in studies so far.

‍